Health ❯ Healthcare ❯ Cancer Statistics

Survival Rates

Patient Outcomes Pancreatic Cancer Survival Mortality Rates Treatment Resistance Treatment Options Adenocarcinoma Government Initiatives Metastatic TNBC Statistics Overall Survival Endometrial Cancer Statistics Diagnosis Trends Progression-Free Survival

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

An FDA early-access program has triggered heavy demand that is straining cancer centers.

B7-H3 ADC Ifinatamab Deruxtecan Shows 48% Response in Relapsed ES-SCLC in Phase 2

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS